Skip to main content

Table 2 Prevalence of risk factors by registered mode of transmission, sex and age

From: Improved ascertainment of modes of HIV transmission in Ukraine indicates importance of drug injecting and homosexual risk

 

Risk factor

Registered mode of transmission

HET

IDU

MSM

OTH

Total

N

Col %

N

Col %

N

Col %

N

Col %

N

Col %

Row %

 

Row %

 

Row %

 

Row %

 

Row %

 

Men

Total

609

42.2%

574

75.9%

59

93.7%

11

47.8%

1253

54.8%

48.6%

 

45.8%

 

4.7%

 

0.9%

 

100.0%

 

het

590

96.9%

563

98.1%

39

66.1%

11

100.0%

1203

96.0%

49.0%

 

46.8%

 

3.2%

 

1.0%

 

100.0%

 

hrh

310

51.2%

411

71.7%

11

18.6%

6

54.5%

738

59.1%

42.0%

 

55.7%

 

1.5%

 

0.8%

 

100.0%

 

sti

221

38.2%

239

44.4%

31

53.4%

3

27.3%

494

41.7%

44.7%

 

48.4%

 

6.3%

 

0.6%

 

100.0%

 

idu

220

36.3%

503

87.8%

6

10.3%

6

54.5%

735

58.9%

29.9%

 

68.4%

 

0.8%

 

0.9%

 

100.0%

 

hcv

293

49.1%

452

80.9%

6

10.7%

4

40.0%

755

61.8%

38.8%

 

59.9%

 

0.8%

 

0.5%

 

100.0%

 

hbv

255

42.7%

342

61.3%

27

48.2%

4

40.0%

628

51.4%

40.6%

 

54.5%

 

4.3%

 

0.6%

 

100.0%

 

msm

46

7.8%

34

6.1%

49

83.1%

1

9.1%

130

10.6%

35.4%

 

26.2%

 

37.7%

 

0.7%

 

100.0%

 

nos

95

15.9%

51

9.2%

7

12.5%

1

9.1%

154

12.7%

61.7%

 

33.1%

 

4.5%

 

0.7%

 

100.0%

 

pen

360

64.6%

398

74.8%

21

43.8%

10

90.9%

789

68.7%

45.6%

 

50.4%

 

2.7%

 

1.3%

 

100.0%

 

Women

Total

834

57.8%

182

24.1%

4

6.3%

12

52.2%

1032

45.2%

80.8%

 

17.6%

 

0.4%

 

1.2%

 

100.0%

 

het

824

98.8%

177

97.3%

4

100.0%

11

91.7%

1016

98.4%

81.1%

 

17.4%

 

0.4%

 

1.1%

 

100.0%

 

hrh

328

39.5%

129

70.9%

2

50.0%

4

33.3%

463

45.0%

70.8%

 

27.9%

 

0.4%

 

0.9%

 

100.0%

 

sti

286

36.3%

83

49.7%

1

50.0%

4

36.4%

374

38.6%

76.5%

 

22.2%

 

0.3%

 

1.0%

 

100.0%

 

idu

136

16.5%

138

76.2%

1

25.0%

5

41.7%

280

27.5%

48.6%

 

49.3%

 

0.4%

 

1.7%

 

100.0%

 

hcv

301

37.2%

121

68.0%

2

50.0%

2

16.7%

426

42.4%

70.7%

 

28.4%

 

0.5%

 

0.4%

 

100.0%

 

hbv

286

35.3%

97

54.5%

2

50.0%

1

8.3%

386

38.4%

74.1%

 

25.1%

 

0.5%

 

0.3%

 

100.0%

 

msm

0

0.0%

0

0.0%

0

0.0%

0

0.0%

0

0.0%

0.0%

 

0.0%

 

0.0%

 

0.0%

 

0.0%

 

nos

161

19.9%

31

17.4%

1

25.0%

1

10.0%

194

19.3%

83.0%

 

16.0%

 

0.5%

 

0.5%

 

100.0%

 

pen

423

54.3%

119

72.1%

3

75.0%

4

40.0%

549

57.3%

77.0%

 

21.7%

 

0.5%

 

0.8%

 

100.0%

 

<=24

Total

122

8.5%

21

2.8%

14

22.2%

0

0.0%

157

6.9%

77.7%

 

13.4%

 

8.9%

 

0.0%

 

100.0%

 

het

120

98.4%

21

100.0%

9

64.3%

0

0.0%

150

95.5%

80.0%

 

14.0%

 

6.0%

 

0.0%

 

100.0%

 

hrh

40

33.1%

11

52.4%

2

14.3%

0

0.0%

53

34.0%

75.5%

 

20.8%

 

3.7%

 

0.0%

 

100.0%

 

sti

34

30.6%

5

29.4%

7

53.8%

0

0.0%

46

32.6%

73.9%

 

10.9%

 

15.2%

 

0.0%

 

100.0%

 

idu

9

7.5%

11

55.0%

0

0.0%

0

0.0%

20

13.1%

45.0%

 

55.0%

 

0.0%

 

0.0%

 

100.0%

 

hcv

31

25.6%

10

47.6%

0

0.0%

0

0.0%

41

26.3%

75.6%

 

24.4%

 

0.0%

 

0.0%

 

100.0%

 

hbv

31

25.6%

9

42.9%

7

50.0%

0

0.0%

47

30.1%

66.0%

 

19.1%

 

14.9%

 

0.0%

 

100.0%

 

msm

6

24.0%

0

0.0%

12

85.7%

0

0.0%

18

39.1%

33.3%

 

0.0%

 

66.7%

 

0.0%

 

100.0%

 

nos

19

16.5%

1

4.8%

2

14.3%

0

0.0%

22

14.7%

86.4%

 

4.5%

 

9.1%

 

0.0%

 

100.0%

 

pen

58

50.9%

14

66.7%

4

33.3%

0

0.0%

76

51.7%

76.3%

 

18.4%

 

5.3%

 

0.0%

 

100.0%

 

25–44

Total

1023

70.9%

626

82.8%

45

71.4%

18

78.3%

1712

74.9%

59.8%

 

36.6%

 

2.6%

 

1.0%

 

100.0%

 

het

1013

99.0%

618

98.7%

31

68.9%

18

100.0%

1680

98.1%

60.3%

 

36.8%

 

1.8%

 

1.1%

 

100.0%

 

hrh

482

47.2%

457

73.1%

10

22.2%

9

50.0%

958

56.1%

50.3%

 

47.7%

 

1.0%

 

1.0%

 

100.0%

 

sti

368

37.8%

252

43.2%

22

50.0%

4

23.5%

646

39.9%

57.0%

 

39.0%

 

3.4%

 

0.6%

 

100.0%

 

idu

265

26.1%

545

87.1%

6

13.3%

8

44.4%

824

48.4%

32.2%

 

66.1%

 

0.7%

 

1.0%

 

100.0%

 

hcv

435

43.6%

489

80.3%

7

16.7%

5

29.4%

936

56.2%

46.5%

 

52.2%

 

0.7%

 

0.6%

 

100.0%

 

hbv

383

38.4%

365

60.0%

19

45.2%

2

11.8%

769

46.2%

49.8%

 

47.5%

 

2.5%

 

0.2%

 

100.0%

 

msm

26

6.2%

30

6.2%

36

85.7%

1

12.5%

93

9.8%

28.0%

 

32.3%

 

38.7%

 

1.0%

 

100.0%

 

nos

163

16.3%

65

10.7%

6

14.0%

1

6.3%

235

14.1%

69.4%

 

27.7%

 

2.6%

 

0.3%

 

100.0%

 

pen

569

60.1%

432

74.7%

18

50.0%

11

68.8%

1030

65.4%

55.2%

 

41.9%

 

1.7%

 

1.2%

 

100.0%

 

> = 45

Total

298

20.7%

109

14.4%

4

6.3%

5

21.7%

416

18.2%

71.6%

 

26.2%

 

1.0%

 

1.2%

 

100.0%

 

het

281

94.3%

101

92.7%

3

75.0%

4

80.0%

389

93.5%

72.2%

 

26.0%

 

0.8%

 

1.0%

 

100.0%

 

hrh

116

39.5%

72

66.1%

1

25.0%

1

20.0%

190

46.1%

61.1%

 

37.9%

 

0.5%

 

0.5%

 

100.0%

 

sti

105

37.4%

65

62.5%

3

100.0%

3

60.0%

176

44.8%

59.7%

 

36.9%

 

1.7%

 

1.7%

 

100.0%

 

idu

82

27.8%

85

78.7%

1

25.0%

3

60.0%

171

41.5%

48.0%

 

49.7%

 

0.6%

 

1.7%

 

100.0%

 

hcv

128

44.4%

74

69.2%

1

25.0%

1

20.0%

204

50.5%

62.7%

 

36.3%

 

0.5%

 

0.5%

 

100.0%

 

hbv

127

44.1%

65

60.7%

3

75.0%

3

60.0%

198

49.0%

64.1%

 

32.8%

 

1.5%

 

1.6%

 

100.0%

 

msm

14

9.4%

4

5.6%

1

33.3%

0

0.0%

19

8.4%

73.7%

 

21.1%

 

5.2%

 

0.0%

 

100.0%

 

nos

74

25.1%

16

15.4%

0

0.0%

1

20.0%

91

22.4%

81.3%

 

17.6%

 

0.0%

 

1.1%

 

100.0%

 

pen

156

56.5%

71

72.4%

2

50.0%

3

60.0%

232

60.6%

67.2%

 

30.6%

 

0.9%

 

1.3%

 

100.0%

 

Total

 

1443

100.0%

756

100.0%

63

100.0%

23

100.0%

2285

100.0%

63.2%

 

33.1%

 

2.8%

 

0.9%

 

100.0%

 

het

1414

98.0%

740

97.9%

43

68.3%

22

95.7%

2219

97.1%

63.7%

 

33.3%

 

1.9%

 

1.1%

 

100.0%

 

hrh

638

44.4%

540

71.5%

13

20.6%

10

43.5%

1201

52.7%

53.1%

 

45.0%

 

1.1%

 

0.8%

 

100.0%

 

sti

507

37.1%

322

45.7%

32

53.3%

7

31.8%

868

40.3%

58.4%

 

37.1%

 

3.7%

 

0.8%

 

100.0%

 

idu

356

24.9%

641

85.0%

7

11.3%

11

47.8%

1015

44.8%

35.1%

 

63.2%

 

0.7%

 

1.0%

 

100.0%

 

hcv

594

42.2%

573

77.7%

8

13.3%

6

27.3%

1181

53.1%

50.3%

 

48.5%

 

0.7%

 

0.5%

 

100.0%

 

hbv

541

38.5%

439

59.6%

29

48.3%

5

22.7%

1014

45.6%

53.4%

 

43.3%

 

2.9%

 

0.4%

 

100.0%

 

msm

46

7.8%

34

6.1%

49

83.1%

1

9.1%

130

10.6%

35.4%

 

26.2%

 

37.7%

 

0.7%

 

100.0%

 

nos

256

18.2%

82

11.2%

8

13.3%

2

9.5%

348

15.7%

73.6%

 

23.6%

 

2.3%

 

0.5%

 

100.0%

 

pen

783

58.6%

517

74.2%

24

46.2%

14

66.7%

1338

63.5%

58.5%

 

38.6%

 

1.8%

 

1.1%

 

100.0%

 
  1. Risk factors (for definitions see Table 1): het heterosexual exposure, hrh high-risk heterosexual exposure, sti sexually transmitted infections, idu injecting drug use, hcv exposure to HCV, hbv exposure to HBV, msm homosexual exposure, nos nosocomial exposure, pen skin penetration exposure
  2. Modes of transmission: HET heterosexual, IDU injecting drug use, MSM homosexual, OTH other